BML Investment Partners, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for Achilles Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share (ACHL)

Filing Manager: BML Investment Partners, L.P.
Reporting Manager: BML Investment Partners, L.P.
Security: Achilles Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share
Symbol: ACHL
Shares outstanding: 41.1M shares
Disclosed Ownership: 4.1M shares
Ownership: 9.97%
Form type: SCHEDULE 13G/A
Filing time: 13 Feb 2025, 17:02:36 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BML Investment Partners, L.P.	9.97%	4.1M	0	4.1M	Braden M Leonard	BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member